Ascelia Pharma AB's market cap is currently €40.51M. The company's EPS TTM is €-0.018322871999999997; its P/E ratio is ―; Ascelia Pharma AB is scheduled to report earnings on August 21, 2025, and the estimated EPS forecast is €>-0.01. See an overview of income statement, balance sheet, and cash flow financials.
